About 66,000 workers in the EU are estimated to be potentially exposed to beryllium.
The primary routes of human exposure to beryllium and its compounds are through inhalation of dusts and fumes and dermal contact with products containing beryllium. They are carcinogenic to humans (classified as Group 1 by IARC) causing beryllium sensitization, acute and chronic beryllium disease (CBD; sometimes called berylliosis), and lung cancer in humans.
Where risks occur
More about the substance
How symptoms can affect you
What you can do
Solutions and good practices:
References: IARC, CDC, CAREX, OSHA, NIOSH, EC